WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals, Inc. (INO) posted first-quarter net loss attributable to common stockholders of $8.3 million or $0.06 per share, wider than $2.4 million or $0.02 per share in the previous year quarter.
Total revenue for the quarter was $1.69 million, down from $3.12 million in the comparable quarter last year.
On average, four analysts polled by Thomson Reuters expected the company to report a loss of $0.05 per share on revenue of $2.08 million. Analysts' estimates typically exclude special items.
Copyright RTT News/dpa-AFX
© 2012 AFX News
